Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acid-Base Compensation in Chronic Kidney Disease
NCT02427594Phase 1Completed
- Sponsor
- Duke University
- Start
- Apr 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sodium bicarbonate in chronic kidney disease (CKD) (2 arms), sponsored by Duke University. Primary endpoints: Change in ambulatory blood pressure at 2 weeks and Change in urine net acid excretion at 3 weeks. Started Apr 2015; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02427594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427594.